Skip to main content

Table 3 Primary and secondary outcomes: hemoglobin, serum ferritin, TSAT and ESA requirement at 6 month

From: Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial

Parameter

HIP

IV sucrose

p-value

Hgb (g/L)

117 (110–128.8)

113 (107.5-120.3)

0.37

Serum ferritin (ug/L)

85.5 (44–104)

244 (71.5-298)

0.004

TSAT (%)

21.5 (17–29)

21.5 (17–27)

0.82

Average ESA dose at 6 month (ug/month)

60 (7 patients)

50 (5 patients)

0.56